Press Releases - WDM Group PR Network
Tonix Pharmaceuticals Highlights Therapeutic Programs on CEONEWS.Tv
Contacts:
Tonix Pharmaceuticals Holding Corp.
Benjamin Selzer
Chief Operating Officer
(212) 980-9155 x106
Email Contact
LHA
Anne Marie Fields
(212) 838-3777
Email Contact
or
Bruce Voss
(310) 691-7100
Email Contact
Agile Therapeutics to Present at CBI's Forum on Phase II-III Clinical Study Optimization
Contact
Chantal Beaudry/Karen Famighetti for Agile Therapeutics
212-867-1762
cbeaudry@lazarpartners.com
kfamighetti@lazarpartners.com
Horizon Pharma Prices $75 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
Contacts
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Email Contact
Media
Geoff Curtis
DJE Science
312-550-8138
Email Contact
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
Email Contact
Ablynx and Its Partner Advance Nanobody Candidate ALX-0751 in Pre-Clinical Development
Acura Pharmaceuticals Announces Paragraph IV ANDA Filing for OXECTA(R)
Contact:
Acura Pharmaceuticals, Inc.
for Acura Investor Relations
Email Contact
847-705-7709
for Acura Media Relations
Email Contact
847-705-7709
MorphoSys's MOR103 Antibody Demonstrates Excellent Safety and Efficacy in Rheumatoid Arthritis Patients
Einstein-Montefiore Scientists Awarded NCI Grants to Study "Provocative Questions" in Cancer Research
For More Information, Contact:
Warren C. Lau
President & CEO
MetaStat, Inc.
(973) 744-7618
New Classroom Program Takes Aim at Bullying Prevention
Media Contact:
Courtney Manders
Stacey Bender
Bender Hammerling Group
(973) 744-0707
Courtney.Manders@bhgpr.com
Stacey.Bender@bhgpr.com
New Research Released at salesforce.com's Dreamforce 2012 Shows Companies Responding Faster to Leads
Contact:
A. Cory Maloy
Snapp Conner PR
801-319-7900
Email Contact


